Journal of Rare Cardiovascular Diseases: Your guide to the latest developments in the field – and to your RCD patient management

Journal Title: Journal of Rare Cardiovascular Diseases - Year 2013, Vol 1, Issue 4

Abstract

Dear Readers, Dear Friends and Colleagues, It is a pleasure to deliver at your hand the next (already the fourth!) issue of your quarterly Journal of Rare Cardiovascular Diseases. We are happy that, with your continued submissions, we are able to publish the journal regularly, and that the Journal has established its natural presence in the family of cardiovascular journals. Fulfilling the principal aim of the Journal, the submissions to this issue have been accepted on a key basis of their relevance to your expanding knowledge and management of your Rare Cardiovascular Disease (RCD) patients. We begin with a review on Ebstein anomaly by a prominent paediatric cardiac surgeon, Dr Jacek Pajak, who performed complex surgeries in a some key centers in the world prior to taking the position of the Head of Paeditric Cardiac Sugery in the Medical University of Silesia in Katowice. Ebstein anomaly patients pose significant decision‑making challenges in every‑day clinical practice of RCD.

Authors and Affiliations

Piotr Podolec

Keywords

Related Articles

Cardiac sarcoidosis – management and prognosis (RCD code: III‑3A.3)

Sarcoidosis is a systemic, granulomatous disease of unknown etiology. Cardiac involvement in the course of sarcoidosis occurs in 5% of patients. However, about 25% of patient with systemic/pulmonary sarcoidosis might pre...

The role of biomarkers as an alternative and completion of the diagnostic and therapeutic pathway in patients with aortic stenosis (RCD code: VIII)

Aortic stenosis (AS) is the most frequent type of valvular heart disease. Clinically, it presents as calcific and congenital AS. Calcific AS is often age dependent and affects 2–7% of people over 65 years of age. Many cl...

Different biochemical profile of stable and decompensated systolic heart failure patients due to ischemic or dilated cardiomyopathy hospitalized in the tertiary cardiology center (RCD code: III-1)

Aim: This study aims to compare the extended biochemical profile of unselected and consecutive systolic heart failure (SHF) patients admitted electively and urgently to the tertiary cardiology center. Methods: This study...

Evaluation of arterial stiffness in patients with coronary atherosclerosis, cardiac syndrome X and systemic lupus erythematosus (RCD code: I-3C.1)

Objectives: Arterial stiffness manifested by high pulse wave velocity (PWV) consists a risk factor of atherosclerosis and cardio-vascular complications. Systemic lupus erythematosus (SLE) is a generalized autoimmune dise...

Right atrial myxoma in a patient with Budd‐Chiari syndrome

Budd‐Chiari syndrome (BCS) is a rare clinical disorder which is caused by obstruction of the major hepatic veins or suprahepatic portion of the inferior vena cava. Either thrombosis or a mechanical venous obstruction may...

Download PDF file
  • EP ID EP248131
  • DOI 10.20418/jrcd.vol1no4.126
  • Views 93
  • Downloads 0

How To Cite

Piotr Podolec (2013). Journal of Rare Cardiovascular Diseases: Your guide to the latest developments in the field – and to your RCD patient management. Journal of Rare Cardiovascular Diseases, 1(4), 137-138. https://europub.co.uk./articles/-A-248131